Incidence and Histopathological Behavior of Papillary Microcarcinomas: Study of 429 cases

@article{Pakdaman2008IncidenceAH,
  title={Incidence and Histopathological Behavior of Papillary Microcarcinomas: Study of 429 cases},
  author={M N Pakdaman and Louise Rochon and Olguta Gologan and Michael Tamilia and Natasha Garfield and Michael P. Hier and Martin J. Black and Richard J. Payne},
  journal={Otolaryngology–Head and Neck Surgery},
  year={2008},
  volume={139},
  pages={718 - 722}
}

Figures and Tables from this paper

Treatment for papillary thyroid microcarcinoma
TLDR
PTMC showed a high incidence of multifocality and lymph node metastasis in the level VI central compartment, and the optimal surgical strategy for PTMC was total thyroidectomy and central compartment node dissection.
Clinical Significance of Tumor Size in Papillary Thyroid Microcarcinoma: a Meta-Analysis
TLDR
It is shown that tumor size in PTMC is associated with high-risk clinicopathologic characteristics and tumor recurrence, and these findings may be helpful to decide treatment plans for patients with PTMC larger than 5 mm.
Differences in the Form of Presentation between Papillary Microcarcinomas and Papillary Carcinomas of Larger Size
TLDR
PTMCs show significant differences compared to PTCs of larger size in the form of presentation, and it is possible that the classic risk factors, such as age, must be cautiously interpreted in the current increasing subgroup of PTMCs.
No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period
TLDR
With applied interventions a favorable course was confirmed in the majority of patients without differences in recurrence or persistence during the last three decades in patients with papillary thyroid microcarcinoma.
Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma
TLDR
Lymph node metastasis is known to be a significant predictor of locoregional recurrence in patients with PTC and PTMC, and multivariate logistic regression analysis showed that sex, age, tumor size, multifocality, bilaterality, extrathyroidal extension, clinical suspicion, and chronic lymphocytic thyroiditis were not significantly correlated with an increased risk for CLNM.
Surgical practice patterns in the treatment of papillary thyroid microcarcinoma.
TLDR
Most surgeons seemed to follow national guidelines regarding the surgical treatment of papillary thyroid microcarcinoma, however, significant differences in the treatment and perception of PTMC exist based on surgical training and location.
Papillary Thyroid Microcarcinoma - Do Classical Staging Systems Need to Be Changed?
TLDR
The wide availability of ultrasonography (US) and fine needle aspiration biopsy (FNAB), as well as the improved accuracy of histopathological examination of surgical samples are indicated as causes of this so-called spreading of the epidemic.
Papillary thyroid microcarcinoma: Is active surveillance always enough?
TLDR
This review aims to summarise active surveillance data for PTMC and identify clinical features that may differentiate the indolent majority from those PTMCs that exhibit early disease progression and metastasis.
Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis
TLDR
Awareness and better understanding of the characteristics of this tumor and manage it as an individual and valuable tumor can take an effective step in promoting public health practice.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
TLDR
Among patients with PTMC, tumor size more than 8 mm is associated with more aggressive disease, and there were no differences in the clinical characteristics between those with incidental PTMC and those with suspected thyroid carcinoma.
Incidental papillary microcarcinoma of the thyroid—factors affecting lymph node metastasis
TLDR
Patients with thyroid PMC in low-risk group with multifocal tumors and with capsule invasion may have increased risk of lymph node metastasis, and must be considered in follow-up of the patients who have these factors.
Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
  • D. Lim, K. Baek, S. Kang
  • Medicine
    Thyroid : official journal of the American Thyroid Association
  • 2007
TLDR
The expression of molecular markers, such as EGFR and COX-2, may have a role in the prognosis of PTMC and a more tailored management approach appears to be necessary for patients with PTMC.
Papillary thyroid microcarcinoma: a surgical perspective.
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience
TLDR
The clinical and histopathological records of 149 consecutive patients with papillary thyroid microcarcinoma, homogeneously studied and operated on by the same surgeon in the period 1990 to 2001, were reviewed and no recurrence was observed in patients treated by total thyroidectomy and 131I.
Clinical features and therapeutic implication of papillary thyroid microcarcinoma.
TLDR
This review addresses the issue of definition, treatment, and follow-up of papillary thyroid microcarcinomas and raises therapeutic implications.
Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease.
TLDR
PTMC is not an uncommon incidental finding after surgery for presumably benign thyroid disease, but the possibility of an underlying PTMC should be taken into account in the management of patients with nodular thyroid disease; total/near total thyroidectomy should be considered, at least in selected patients with presumably benign nodularity thyroid disease.
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases.
TLDR
Baseline histopathological characteristics and serum Tg levels off l-T(4) at first postsurgical evaluation can accurately predict the risk of relapse in small papillary thyroid cancers.
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
TLDR
Patients with DTC have an overall increased standardized incidence rate for second primary tumors, but not for secondPrimary tumors following I-131 therapy, which suggests a common etiologic and/or genetic mechanism instead of a causal relation.
...
1
2
3
4
...